Literature DB >> 15029243

Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.

Jayne M Stommel1, Geoffrey M Wahl.   

Abstract

p53 activation prevents the proliferation of genetically unstable cells. Conversely, p53 antagonism by its transcriptional target, the E3 ubiquitin ligase MDM2, is critical for the viability of unstressed, cycling cells. We demonstrate that MDM2 induces the degradation of p53 in both the nucleus and the cytoplasm. As p53 and MDM2 accumulate in the nuclei of stressed cells, we investigated mechanisms enabling p53 activation despite the high MDM2 levels generated during a DNA-damage response. We show that DNA damage destabilized MDM2 by a mechanism involving damage-activated kinases and MDM2 auto-ubiquitination. p53 was stable and transcriptionally active when MDM2 was unstable, but became unstable and inactive as the damage response waned and MDM2 stabilized. Importantly, blocking MDM2 destabilization in DNA-damaged cells prevented p53 target gene activation. Our data reveal that controlled MDM2 degradation is an important new step in p53 regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15029243      PMCID: PMC391059          DOI: 10.1038/sj.emboj.7600145

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.

Authors:  D A Sharp; S A Kratowicz; M J Sank; D L George
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

2.  Stress signals utilize multiple pathways to stabilize p53.

Authors:  M Ashcroft; Y Taya; K H Vousden
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.

Authors:  S Fang; J P Jensen; R L Ludwig; K H Vousden; A M Weissman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

4.  A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals.

Authors:  B R Henderson; A Eleftheriou
Journal:  Exp Cell Res       Date:  2000-04-10       Impact factor: 3.905

5.  The MDM2 RING-finger domain is required to promote p53 nuclear export.

Authors:  R K Geyer; Z K Yu; C G Maki
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

6.  An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.

Authors:  S D Boyd; K Y Tsai; T Jacks
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

7.  Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.

Authors:  A Böttger; V Böttger; A Sparks; W L Liu; S F Howard; D P Lane
Journal:  Curr Biol       Date:  1997-11-01       Impact factor: 10.834

8.  Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1.

Authors:  J Zimmermann; D Erdmann; I Lalande; R Grossenbacher; M Noorani; P Fürst
Journal:  Oncogene       Date:  2000-06-08       Impact factor: 9.867

9.  Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding.

Authors:  K Sakaguchi; S Saito; Y Higashimoto; S Roy; C W Anderson; E Appella
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

10.  Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.

Authors:  R Honda; H Yasuda
Journal:  Oncogene       Date:  2000-03-09       Impact factor: 9.867

View more
  154 in total

1.  Regulation of the DNA damage response by p53 cofactors.

Authors:  Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  Biophys J       Date:  2012-05-15       Impact factor: 4.033

2.  Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage.

Authors:  Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

3.  SILAC analysis of oxidative stress-mediated proteins in human pneumocytes: new role for treacle.

Authors:  Xunbao Duan; Steve G Kelsen; Allen B Clarkson; Rong Ji; Salim Merali
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

4.  Serotype-specific inactivation of the cellular DNA damage response during adenovirus infection.

Authors:  Natalie A Forrester; Garry G Sedgwick; Anoushka Thomas; Andrew N Blackford; Thomas Speiseder; Thomas Dobner; Philip J Byrd; Grant S Stewart; Andrew S Turnell; Roger J A Grand
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

Review 5.  Making sense of ubiquitin ligases that regulate p53.

Authors:  Abhinav K Jain; Michelle Craig Barton
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

6.  A stapled p53 helix overcomes HDMX-mediated suppression of p53.

Authors:  Federico Bernal; Mark Wade; Marina Godes; Tina N Davis; David G Whitehead; Andrew L Kung; Geoffrey M Wahl; Loren D Walensky
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

7.  Influence of parameter values on the oscillation sensitivities of two p53-Mdm2 models.

Authors:  Christian E Cuba; Alexander R Valle; Giancarlo Ayala-Charca; Elizabeth R Villota; Alberto M Coronado
Journal:  Syst Synth Biol       Date:  2015-06-05

8.  Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage.

Authors:  Yaron Pereg; Suzanne Lam; Amina Teunisse; Sharon Biton; Erik Meulmeester; Leonid Mittelman; Giacomo Buscemi; Koji Okamoto; Yoichi Taya; Yosef Shiloh; Aart G Jochemsen
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

9.  Mathematical model identifies effective P53 accumulation with target gene binding affinity in DNA damage response for cell fate decision.

Authors:  Tingzhe Sun; Dan Mu; Jun Cui
Journal:  Cell Cycle       Date:  2018-12-10       Impact factor: 4.534

Review 10.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.